New Zealand markets open in 4 hours 43 minutes

Biofrontera AG (B8FKD.XC)

Cboe UK - Cboe UK Real-time price. Currency in EUR
Add to watchlist
3.0100-3.0100 (-50.00%)
At close: 08:02AM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
30,163
32,249
25,738
28,787
30,346
-
Cost of revenue
6,220
6,243
4,757
3,913
3,536
-
Gross profit
23,942
26,005
20,981
24,873
26,810
-
Operating expenses
Research development
7,755
7,846
7,128
7,009
4,789
-
Selling general and administrative
12,167
13,378
12,262
53,204
29,632
-
Total operating expenses
19,922
21,224
19,390
60,213
34,421
-
Operating income or loss
4,020
4,781
1,591
-35,340
-7,611
-
Interest expense
14
15
163
3,720
3,080
-
Total other income/expenses net
-
-
-
-
-2,419
21,184
Income before tax
-1,439
-2,127
-43,210
35,683
-12,697
-
Income tax expense
-1,837
-1,758
956
2,397
326
-
Income from continuing operations
398
-369
-44,166
33,286
-13,023
-
Net income
398
-369
-44,166
37,747
-13,023
-
Net income available to common shareholders
398
-369
-44,166
37,747
-13,023
-
Basic EPS
-0.10
-0.21
-16.17
13.66
-4.82
-
Diluted EPS
-0.10
-0.21
-16.17
13.46
-4.82
-
Basic average shares
64,813
3,038
2,737
2,757
2,697
-
Diluted average shares
64,813
3,038
2,737
2,823
2,697
-